XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.39%)
As of: Sep 30, 2026 · 10:14 AM EDT

XORTX Therapeutics (XRTX) Total Current Liabilities (2020 - 2026)

Updated

XORTX Therapeutics (XRTX) reported Total Current Liabilities of $679,522 for the quarter ended Jun 30, 2026, down 4.5% from $711,455 a year earlier and down 21.1% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Total Current Liabilities (2020 - 2026) Analysis & Trends

As of Dec 31, 2025, XORTX Therapeutics posted Total Current Liabilities of $599,071, down 21.0% from the prior year.

  • Total Current Liabilities has declined for three consecutive years, with a five-year compound annual growth rate of -4.9% (years ended Dec 2020 to Dec 2025).
  • By year, Total Current Liabilities came in at $757,990 in the year ended Dec 31, 2024 (-8.2%), $825,938 in the year ended Dec 31, 2023 (-45.3%), $1.51 million in the year ended Dec 31, 2022 (+173.3%) and $552,948 in the year ended Dec 31, 2021 (-28.4%).
  • Five-year quarterly Total Current Liabilities spans a low of $340,928 in the quarter ended Mar 31, 2024 and a high of $9.59 million in the quarter ended Sep 30, 2021.
  • Year over year, Total Current Liabilities gained in three of the last eight quarters, with growth averaging 24.4%.
  • The high point for year-over-year Total Current Liabilities in five years was the quarter ended Jun 30, 2024 (growth of 419.4%); the low point was the quarter ended Jun 30, 2023 (a decline of 86.5%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $860,988 (quarter ended Mar 31, 2026), $599,071 (quarter ended Dec 31, 2025) and $837,408 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 XORTX Therapeutics 1.62 Mn -1.68 Mn - 679,522.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 679,522.00
Mar 31, 2026 860,988.00
Dec 31, 2025 599,071.00
Sep 30, 2025 837,408.00
Jun 30, 2025 711,455.00
Mar 31, 2025 757,350.00
Dec 31, 2024 757,990.00
Sep 30, 2024 1.72 Mn
Jun 30, 2024 2.09 Mn
Mar 31, 2024 340,928.00
Dec 31, 2023 825,938.00
Sep 30, 2023 553,757.00
Jun 30, 2023 403,262.00
Mar 31, 2023 599,788.00
Dec 31, 2022 1.51 Mn
Sep 30, 2022 3.26 Mn
Jun 30, 2022 2.98 Mn
Mar 31, 2022 3.98 Mn
Dec 31, 2021 556,127.80
Sep 30, 2021 9.59 Mn
API Access

XORTX Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=XRTX&period=max&api_key=YOUR_API_KEY